Atlas Trials

Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma

Clinical trial NCT02276248 · COMPLETED

Trial details

NCT number
NCT02276248
Sponsor
Chinese Academy of Medical Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Stage I/II Extranodal NK/T-cell Lymphoma
Start date
2010-06-01
Primary completion
2016-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.